Back to search

Article

In Silico Molecular Docking and Molecular Dynamic Simulation of Potential Inhibitors of 3C-like Main Proteinase (3CLpro) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Using Selected African Medicinal Plants

2020-06-18

Abstract excerpt

The Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) is an infectious virus that causes mild to severe life-threatening upper respiratory tract infection. The virus emerged in Wuhan, China in 2019, and later spread across the globe. Its genome has been completely sequenced and based on the genomic information, the virus possessed 3C-Like Main Protease (3CLpro), an essential multifunctional enzyme that plays a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
551790a7-7c00-540a-8c75-110c50a3be09
DOI
10.26434/chemrxiv.12480434.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In Silico Molecular Docking and Molecular Dynamic Simulation of Potential Inhibitors of 3C-like Main Proteinase (3CLpro) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Using Selected African Medicinal PlantsDOI 10.26434/chemrxiv.12480434.v1
Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual ScreeningSemantic proximity
Bioinformatics approaches to investigate the phytochemicals of Centella asiatica against the main protease of SARS-CoV-2Semantic proximity
ABBV-744 and Onalespid as Potential Inhibitors of SARS-CoV-2 main Protease Enzyme: A Promising Therapeutics in COVID-19?Semantic proximity
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approachesSemantic proximity
Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studySemantic proximity
Molecular Docking and Clinical Study of Inhibition of Phytochemical Compounds of Nigella Sativa, Matricaria Chamomilla and Origanum Vulgare L on COVID_19 MproSemantic proximity
Genetic Algorithm-Based Docking of Potent Inhibitors Against SARS-CoV-2 Main Protease: A Comparison Between Natural Products and Synthetic Drugs.Semantic proximity
In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics SimulationsSemantic proximity
Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational ApproachesSemantic proximity
Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A Medicinal Chemistry approach.Semantic proximity
Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV‑2 Main ProteaseSemantic proximity
Old Arsenal to Combat New Enemy: Repurposing of Commercially Available FDA Approved Drugs Against Main Protease of SARS-CoV2.Semantic proximity
Select a neighboring publication to make it the new centre.